Abstract
A simple method for highly sensitive and selective detection of M.SssI CpG methyltransferase (M.SssI MTase) activity is developed, leveraging on the portability and ease of use of a personal glucose meter (PGM). Briefly, DNA-invertase conjugates are hybridized with their complementary DNA strands pre-immobilized on magnetic beads. The 5′-CCGG-3′ sequence present in the DNA duplexes serves as the recognition site for both Hpa II restriction enzyme and M.SssI MTase (5′-CG-3′). Hpa II restriction enzyme specifically cleaves at unmethylated 5′-CCGG-3′ sequence, and the invertase that remains on the methylated DNA catalyzes the hydrolysis of sucrose to glucose and fructose. It is found that the amount of glucose is proportional to the M.SssI MTase methylation activity in the range of 0.5 to 80 U/mL with a detection limit of 0.37 U/mL. Due to the specific recognition sequence present in the DNA strands, this method also shows high selectivity for M.SssI MTase. In addition, inhibition studies with 5′-azacytidine demonstrate the capability of inhibition screening using this method.
Similar content being viewed by others
Change history
27 July 2018
We should like to call your attention to the fact that Si Ying Png’s name was misspelled in the original publication: it should be Si Ying Png.
References
Bird AP. CpG-rich islands and the function of DNA methylation. Nature. 1986;321:209–13.
Gros C, Fahy J, Halby L, Dufau I, Erdmann A, Gregoire JM, et al. DNA methylation inhibitors in cancer: recent and future approaches. Biochimie. 2012;94:2280–96.
Cheng X, Roberts RJ. AdoMet-dependent methylation, DNA methyltransferases and base flipping. Nucleic Acids Res. 2001;29:3784–95.
Herman JG, Merlo A, Mao L, Lapidus RG, Issa JPJ, Davidson NE, et al. Inactivation of the CDKN2/pl6/MTSl gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 1995;55:4525–30.
Ehrlich M. DNA methylation in cancer: too much, but also too little. Oncogene. 2002;21:5400–13.
Auclair G, Weber M. Mechanisms of DNA methylation and demethylation in mammals. Biochimie. 2012;94:2202–11.
Levenson VV, Melnikov AA. DNA methylation as clinically useful biomarkers—light at the end of the tunnel. Pharmaceuticals. 2012;5:94–113.
Maxam AM, Gilbert W. A new method for sequencing DNA. Proc Natl Acad Sci U S A. 1997;74:560–4.
Fedoreyeva LI, Vanyushin BF. N 6-Adenine DNA-methyltransferase in wheat seedlings. FEBS Lett. 2002;514:305–8.
Fraga MF, Uriol E, Diego LB, Berdasco M, Esteller M, Canal MJ, et al. High-performance capillary electrophoretic method for the quantification of 5-methyl 2′-deoxycytidine in genomic DNA: application to plant, animal and human cancer tissues. Electrophoresis. 2002;23:1677–81.
Ge C, Fang Z, Chen J, Liu J, Lu X, Zeng L. A simple colorimetric detection of DNA methylation. Analyst. 2012;137:2032–5.
Bi S, Zhao T, Luo B, Zhu JJ. Hybridization chain reaction-based branched rolling circle amplification for chemiluminescence detection of DNA methylation. Chem Commun. 2013;49:6906–8.
Worm J, Aggerholm A, Guldberg P. In-tube DNA, methylation profiling by fluorescence melting curve analysis. ClinChem. 2001;47:1183–9.
Cedar H, Solage A, Glaser G, Razin A. Direct detection of methylated cytosine in DNA by use of the restriction enzyme MspI. Nucleic Acids Res. 1979;6:2125–32.
Deng HM, Yang XJ, Yeo SPX. GaoZQ. Highly sensitive electrochemical methyltransferase activity assay. Anal Chem. 2014;86:2117–23.
Ferri S, Kojima K, Sode K. Review of glucose oxidases and glucose dehydrogenases: a bird's eye view of glucose sensing enzymes. J Diabetes Sci Technol. 2011;5:1068–76.
Xiang Y, Lu Y. Using personal glucose meters and functional DNA sensors to quantify a variety of analytical targets. Nat Chem. 2011;3:697–703.
Xu J, Jiang B, Xie J, Xiang Y, Yuan R, Chai Y. Sensitive point-of-care monitoring of HIV related DNA sequences with a personal glucometer. Chem Commun. 2012;48:10733–5.
Ma X, Chen Z, Zhou J, Weng W, Zheng O, Lin Z, et al. Aptamer-based portable biosensor for platelet-derived growth factor-BB (PDGF-BB) with personal glucose meter readout. BiosensBioelectron. 2014;55:412–6.
Xiang Y, Lu Y. Portable and quantitative detection of protein biomarkers and small molecular toxins using antibodies and ubiquitous personal glucose meters. Anal Chem. 2012;84:4174–8.
Xiang Y, Lu Y. An invasive DNA approach toward a general method for portable quantification of metal ions using a personal glucose meter. Chem Commun. 2013;49:585–7.
Yan L, Zhu Z, Zou Y, Huang Y, Liu D, Jia S, et al. Target-responsive “sweet” hydrogel with glucometer readout for portable and quantitative detection of non-glucose targets. J Am Chem Soc. 2013;135:3748–51.
Kupper D, Reuter M, Meisel A, Kruger DH. Reliable detection of DNA CpG methylation profiles by the isoschizomers MspI/HpaII using oligo-nucleotide stimulators. BioTechniques. 1997;23:843–7.
Gao C, Li H, Liu Y, Wei W, Zhang Y, Liu S. Label-free fluorescence detection of DNA methylation and methyltransferase activity based on restriction endonuclease Hpa II and exonuclease III. Analyst. 2014;139:6387–92.
Xing XW, Tang F, Wu J, Chu JM, Feng YQ, Zhou X, et al. Sensitive detection of DNA methyltransferase activity based on exonuclease-mediated target recycling. Anal Chem. 2014;86:11269–74.
Yang Z, Wang F, Wang M, Yin H, Ai S. A novel signal-on strategy for M. SssI methyltransfease activity analysis and inhibitor screening based on photoelectrochemical immunosensor. Biosens Bioelectron. 2015;66:109–14.
Yang X, Han H, De Carvalho DD, Lay FD, Jones PA, Liang G. Gene body methylation can alter gene expression and is a therapeutic target in cancer. Cancer Cell. 2014;26:577–90.
Christman JM. 5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene. 2002;21:5483–95.
Stresemann C, Lyko F. Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine. Int J Cancer. 2008;2008:8–13.
Kiziltepe T, Hideshima T, Catley L, Raje N, Yasui H, Shiraishi N, et al. 5-Azacytidine, a DNA methyltransferase inhibitor, induces ATR-mediated DNA double-strand break responses, apoptosis, and synergistic cytotoxicity with doxorubicin and bortezomib against multiple myeloma cells. Mol Cancer Ther. 2007;6:1718–27.
Keiko S, Yutaka K. Targeting cancer epigenetics: linking basic biology to clinical medicine. Adv Drug Del Rev. 2015;95:56–64.
Acknowledgments
The authors thank the Ministry of Education for the financial support (R-143-000-588-112). H.D. is grateful for her scholarship from the Ministry of Education, Republic of Singapore.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Deng, H., Peng, S.Y. & Gao, Z. Highly sensitive detection of M.SssI DNA methyltransferase activity using a personal glucose meter. Anal Bioanal Chem 408, 5867–5872 (2016). https://doi.org/10.1007/s00216-016-9701-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-016-9701-y